Back

Prognostic relevance of baseline right ventricular echocardiographic evaluation in patients undergoing valvular surgery with tricuspid intervention

2 September 2024 (11:00 - 11:40)
Organised by: Logo
Congress Presentation Part of: Advances in surgery for valvular heart diseases Surgery ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Marcelo Luque

Hospital San Borja Arriaran, Santiago (Chile)

6 More presentations in this session

Presentation thumbnail
Temporal trends in mitral valve surgery in Denmark: changes in patient characteristics and outcomes from 1996 to 2021
Doctor L. Ostergaard (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Prosthesis-patient mismatch is associated with long-term mortality following surgical aortic valve replacement
Doctor A. Mazine (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Bioprosthetic versus mechanical prostheses in patients aged 50 to 70 years undergoing aortic valve replacement surgery: outcomes analysis from propensity score matching
Doctor W. Courtney (Cavan, IE)
Abstract Slides Video
Presentation thumbnail
Association between left atrial dysfunction and adverse outcomes after tricuspid valve surgery for atrial functional tricuspid regurgitation
Doctor J. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of a novel preoperative stratification method versus traditional scores in patients with severe aortic stenosis undergoing aortic valve surgery
Doctor C. Espinoza Romero (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in surgery for valvular heart diseases

The Event

Event poster

ESC Congress 2024

2 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of tricuspid regurgitation and right ventricular dysfunction after cardiac resynchronization therapy
thumbnail
Congress Session
Estimating prognosis after atrial ventricular: valvular intervention
thumbnail
Congress Session
Tricuspid valve intervention: ready for prime time?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources